Relevium Technologies Inc
XTSX:RLV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/IC
Enterprise Value to Invested Capital (EV/IC) ratio compares a company`s total enterprise value to the capital invested in its business. It shows how efficiently the company`s market value reflects the funds used to generate returns.
Enterprise Value to Invested Capital (EV/IC) ratio compares a company`s total enterprise value to the capital invested in its business. It shows how efficiently the company`s market value reflects the funds used to generate returns.
Valuation Scenarios
If EV/IC returns to its 3-Year Average (13 371.8), the stock would be worth CA$37 (0% downside from current price).
| Scenario | EV/IC Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 13 371.8 | CA$37 |
0%
|
| 3-Year Average | 13 371.8 | CA$37 |
0%
|
| 5-Year Average | 7.9 | CA$0.02 |
-100%
|
| Industry Average | 9.8 | CA$0.03 |
-100%
|
| Country Average | 1.7 | CA$0 |
-100%
|
Forward EV/IC
Today’s price vs future invested capital
Peer Comparison
| Market Cap | EV/IC | P/E | ||||
|---|---|---|---|---|---|---|
| CA |
|
Relevium Technologies Inc
XTSX:RLV
|
12.2B CAD | 13 371.8 | -4 624.4 | |
| FR |
|
L'Oreal SA
PAR:OR
|
195.4B EUR | 4.3 | 31.9 | |
| UK |
|
Unilever PLC
LSE:ULVR
|
96.1B GBP | 2.6 | 11.7 | |
| IN |
|
Hindustan Unilever Ltd
NSE:HINDUNILVR
|
5.3T INR | 8.7 | 36.4 | |
| UK |
|
HALEON PLC
LSE:HLN
|
30.6B GBP | 1.3 | 18.4 | |
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
28.7B USD | 2.2 | -161.1 | |
| DE |
|
Beiersdorf AG
XETRA:BEI
|
15.5B EUR | 1.7 | 16.5 | |
| JP |
|
Kao Corp
TSE:4452
|
2.7T JPY | 1.9 | 22.1 | |
| IN |
|
Godrej Consumer Products Ltd
NSE:GODREJCP
|
1.1T INR | 7.4 | 59.9 | |
| IN |
|
Dabur India Ltd
NSE:DABUR
|
783.1B INR | 7.8 | 42.5 | |
| JP |
|
Shiseido Co Ltd
TSE:4911
|
1.3T JPY | 1.3 | -31 |
Market Distribution
| Min | 0 |
| 30th Percentile | 1 |
| Median | 1.7 |
| 70th Percentile | 3.7 |
| Max | 95 179.6 |
Other Multiples
Relevium Technologies Inc
Glance View
Relevium Technologies Inc. emerged as a player in the health and wellness sector, operating within the burgeoning landscape of e-commerce and bio-health. The company strategically positioned itself to capitalize on the growing consumer demand for health-related products and services, driven by an increasing global awareness of personal health management. Relevium's business model hinges on developing, acquiring, and commercializing a portfolio of nutraceutical, cosmeceutical, and other health-related products. By leveraging advanced technologies and persistent market analysis, Relevium sought to offer unique solutions that appeal to health-conscious consumers looking for holistic wellness. Fundamentally, Relevium generates revenue through its online platforms, where it markets and sells its branded products, harnessing the power of digital marketing and strategic partnerships. The firm has also been involved in acquisition strategies, aiming to expand its product offerings and enhance its market reach. Through aggressive branding and penetrating diverse distribution channels, Relevium endeavors to create a diversified revenue stream while aligning with sustainable business practices. This approach not only seeks to drive financial growth but also intends to position Relevium as a reliable name in the health and wellness industry, with the agility to adapt to the ever-evolving consumer preferences in this dynamic sector.
